OPY Stock Recent News

Owen Lau, Oppenheimer senior analyst, joins 'Squawk Box' to discuss news of Coinbase announcing that the SEC has agreed to dismiss its enforcement case against the company, what it means for the larger crypto community, and more.

Rupesh Parikh, Oppenheimer managing director and senior analyst, joins 'Squawk Box' to break down Walmart's quarterly earnings results.

TEL AVIV, Israel, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced data fabric technology, has successfully executed important settlements with both Oppenheimer & Co. Inc. and Dominion Capital, eliminating $9.1 million in legacy liabilities. The Company has reduced a combined $16.6 million in claims to a final settlement amount of just $7.5 million, structured under highly favorable installment terms, significantly strengthening HUB's balance sheet and financial flexibility.

FREMONT, CA / ACCESS Newswire / February 20, 2025 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced it will participate in the Oppenheimer 10th Annual Emerging Growth Conference being held virtually February 25-26, 2025. Aehr Test CFO Chris Siu will be hosting virtual meetings with investors throughout the day on Wednesday, February 26th.

PLANTATION, Fla.--(BUSINESS WIRE)--Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the 10th Annual Oppenheimer Emerging Growth Conference on Wednesday, February 26th. Performant's Chief Financial Officer, Rohit Ramchandani, will participate in one-on-one meetings to discuss key topics, including the potential company's impact under the n.

Colin Rusch, Oppenheimer senior research analyst, joins 'Squawk Box' to discuss Tesla's stock performance, the company's autonomous ambitions, impact of Elon Musk's role in Washington, and more.

SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Rick Stewart, Chief Executive Officer of Achieve, will be presenting today at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025, at 10:00 a.m. EST.

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 3:20 pm ET.

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company's management will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12th, 2025 at 11:20am Eastern Time. Investors and attendees that would like to schedule a meeting with DiaMedica's management can contact their Oppenheimer representative to a.

MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced that its CEO, Maria Maccecchini, Ph.D., will present at the Oppenheimer's 35th Annual Healthcare Life Sciences Conference.